Variant report
Variant | nsv430058 |
---|---|
Chromosome Location | chr1:193684343-193702343 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:77)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:193678450..193681158-chr1:193682285..193685229,2 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDC73-2 | chr1:193694731-193694815 | ENSG00000226640.2 |
2 | lnc-CDC73-2 | chr1:193694731-193694815 | XLOC_000509 |
3 | lnc-CDC73-2 | chr1:193695962-193696313 | XLOC_000509 |
4 | lnc-CDC73-2 | chr1:193695962-193696165 | ENSG00000226640.2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252241 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373467696 | chr1:193684614-193684615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565719143 | chr1:193684634-193684635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10921415 | chr1:193684639-193684640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs7541925 | chr1:193684654-193684655 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs551622129 | chr1:193684667-193684668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571354359 | chr1:193684669-193684670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12408312 | chr1:193684673-193684674 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs184621046 | chr1:193684675-193684676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567414539 | chr1:193684676-193684677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536331523 | chr1:193684692-193684693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553020005 | chr1:193684705-193684706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17376854 | chr1:193684728-193684729 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs541364650 | chr1:193684731-193684732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558391007 | chr1:193684735-193684736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12034223 | chr1:193684737-193684738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544043794 | chr1:193684747-193684748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563522078 | chr1:193684755-193684756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17376861 | chr1:193684770-193684771 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs561483193 | chr1:193684777-193684778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189945369 | chr1:193684797-193684798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541308535 | chr1:193684802-193684803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551394600 | chr1:193684819-193684820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367564941 | chr1:193684825-193684826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560492020 | chr1:193684833-193684834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530710923 | chr1:193684880-193684881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17304880 | chr1:193684886-193684887 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs371325731 | chr1:193684923-193684924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7552269 | chr1:193684940-193684941 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs10709208 | chr1:193684951-193684952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535555379 | chr1:193694614-193694615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568222799 | chr1:193694654-193694655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184069536 | chr1:193694680-193694681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528404940 | chr1:193694689-193694690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74328300 | chr1:193694705-193694706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565078560 | chr1:193694729-193694730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536568126 | chr1:193694740-193694741 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs550786840 | chr1:193694762-193694763 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs2031831 | chr1:193694777-193694778 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs536337753 | chr1:193694799-193694800 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs368166597 | chr1:193694805-193694806 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs546589928 | chr1:193694822-193694823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566314899 | chr1:193694831-193694832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75335855 | chr1:193694837-193694838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558126256 | chr1:193694841-193694842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371781996 | chr1:193694879-193694880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4657760 | chr1:193694880-193694881 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs578007137 | chr1:193694889-193694890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540109242 | chr1:193694918-193694919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs41314555 | chr1:193694951-193694952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147794803 | chr1:193694958-193694959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:193684600-193685000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr1:193694600-193695000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
3 | chr1:193695000-193697600 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
4 | chr1:193695800-193697800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr1:193696000-193696200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr1:193696400-193697600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:193696600-193697600 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
8 | chr1:193696800-193697000 | Bivalent Enhancer | H9 Cell Line | embryonic stem cell |
9 | chr1:193696800-193697200 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
10 | chr1:193696800-193697200 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
11 | chr1:193696800-193697600 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
12 | chr1:193697000-193697400 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
13 | chr1:193697600-193697800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
14 | chr1:193698400-193698600 | Enhancers | A549 | lung |
15 | chr1:193698600-193698800 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
16 | chr1:193698600-193699000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr1:193698600-193699400 | Enhancers | Fetal Heart | heart |
18 | chr1:193698600-193699600 | Flanking Active TSS | A549 | lung |
19 | chr1:193698600-193700400 | Enhancers | Hela-S3 | cervix |